A detailed history of Financial Partners Group, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Partners Group, Inc holds 3,857 shares of MRK stock, worth $485,403. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,857
Previous 3,431 12.42%
Holding current value
$485,403
Previous $374,000 35.83%
% of portfolio
0.08%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $48,240 - $56,210
426 Added 12.42%
3,857 $508,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $2,470 - $2,743
24 Added 0.7%
3,431 $353,000
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $61,581 - $67,121
-567 Reduced 14.27%
3,407 $393,000
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $3,808 - $4,249
-37 Reduced 0.92%
3,974 $422,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $2,798 - $3,587
32 Added 0.8%
4,011 $444,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1,775 - $1,994
21 Added 0.53%
3,979 $343,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $3,673 - $4,164
44 Added 1.12%
3,958 $361,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $10,191 - $12,766
141 Added 3.74%
3,914 $319,000
Q3 2021

Nov 05, 2021

SELL
$71.68 - $78.83 $4,802 - $5,281
-67 Reduced 1.74%
3,773 $283,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $2,390 - $2,644
34 Added 0.89%
3,840 $299,000
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $66,105 - $77,865
960 Added 33.73%
3,806 $293,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $11,339 - $12,584
158 Added 5.88%
2,846 $231,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $196,707 - $222,969
2,688 New
2,688 $223,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Financial Partners Group, Inc Portfolio

Follow Financial Partners Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Partners Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Partners Group, Inc with notifications on news.